Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Gains from Investment Securities (2016 - 2026)

Bio-Techne has reported Gains from Investment Securities over the past 17 years, most recently at -$500000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 162.5% year-over-year to -$500000.0; the TTM value through Dec 2025 reached $117.7 million, up 14614.0%, while the annual FY2025 figure was $1.8 million, 56.48% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$500000.0 at Bio-Techne, down from $900000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $135.4 million in Q2 2021 and troughed at -$26.7 million in Q2 2022.
  • A 5-year average of $14.7 million and a median of $950000.0 in 2023 define the central range for Gains from Investment Securities.
  • On a YoY basis, Gains from Investment Securities climbed as much as 3471.43% in 2021 and fell as far as 175.84% in 2021.
  • Year by year, Gains from Investment Securities stood at $25.0 million in 2021, then plummeted by 90.8% to $2.3 million in 2022, then plummeted by 60.87% to $900000.0 in 2023, then dropped by 11.11% to $800000.0 in 2024, then crashed by 162.5% to -$500000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for TECH at -$500000.0 in Q4 2025, $900000.0 in Q3 2025, and $30.6 million in Q2 2025.